Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1

Autor: C Cheneau, S Barthier, J Lemonnier, Fabrice Andre, C Dubot, L Teixeira, A Escande, T De La Motte Rouge, T Petit, L Arnould, Laurent Arnould, Suzette Delaloge, Jerome Lemonnier, A Marti, L Stefani, F Berger, C Levy, P Barthelemy, S Nguyen, M Gardner, A Lortholary, François-Clément Bidard, J Plaza, L Joly, Thibault de la Motte Rouge, F Andre, I Bièche, C Alleaume, R Sabatier, B Lucas, Ivan Bieche, O Derbel, L Venat-Bouvet, F Del Piano, Florian Clatot, Anne-Claire Hardy-Bessard, Frédérique Berger, Margaux Marce, Thomas Bachelot, Anne Pradines, Jean-Luc Canon, Sandrine Marques, M Achille, H Ammarguellat, O Arsene, T Bachelot, C Bernard-Marty, F-C Bidard, N Bonichon-Lamichhane, N Bonnin, R Bouaita, A Boudrant, V-A Brunel, C Chakiba, F Clatot, F Dalenc, A De Gramont, L Deiana, C Delbaldo, V Delecroix, H Desclos, V D'Hondt, N Dohollou, J-M Ferrero, C Foa, J-S Frenel, C Garnier Tixidre, D Genet, O Gisserot, M Gozy, C Greilsamer, J Grenier, F Guinet, A-C Hardy-Bessard, J-P Jacquin, E Lachaier, S Ladoire, A-P Laurenty, R Le Scodan, N Leduc, E Legouffe, C Levache, F Lorchel, N Marques, J Medioni, A Melis, D Mille, D Mollon, L Moreau, I Moullet, M-A Mouret-Reynier, A Najem, H Orfeuvre, J-F Paitel, B Pistilli, C Riedl, P Soulie, D Spaeth, F Trouboul, C Valmar, H Vegas, A Zannetti, FC Bidard, S Delaloge, A Pradines, JL Canon, S Marques

Publikováno v: BMJ Open, Vol 12, Iss 3 (2022)

Introduction The combination of a CDK4/6 inhibitor with an aromatase inhibitor (AI) has recently become the gold standard for AI-sensitive first line treatment of oestrogen receptor-positive (ER+) HER2-negative (HER2−) advanced breast cancer. Howev

Externí odkaz: https://doaj.org/article/8faf6bbc845f4ceeb90674dd08e198da

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

EE608 Cost Effectiveness Analysis of a Large (Foundation Medicine) Versus a Home-Based Medium Gene Panel for Exome Sequencing: Results of the Profiler 02 Randomized Clinical Trial

Autor: L Perrier, O Tredan, M Morelle, N Penel, P Fournel, L Greillier, F Ghiringhelli, D Tosi, F Bertucci, M Campone, JP Delord, D Pouessel, G Garin, S Chabaud, C Gomez-Roca, D Pannier, M Brahmi, M Fabbro, ME Garcia, I Ray-Coquard, M Viala, A Italiano, P Cassier, A Dufresne, V Attignon, I Treilleux, A Viari, T de la Motte Rouge, X Durando, D Perol, JY Blay

Publikováno v: ISPOR Europe 2022
ISPOR Europe 2022, Nov 2022, Vienne (Austria), Austria. 25 (12), pp.S175, 2022, ⟨10.1016/j.jval.2022.09.847⟩

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f99820299c75a22fa71f446acf858118
https://shs.hal.science/halshs-03961247

Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program

Autor: D. Bello Roufai, A. Gonçalves, T. De La Motte Rouge, S. Akla, C. Blonz, J. Grenier, J. Gligorov, M. Saghatchian, C. Bailleux, H. Simon, I. Desmoulins, Z. Tharin, E. Renaud, M. Bertho, M-A Benderra, S. Delaloge, L. Robert, P. Cottu, J. Y. Pierga, D. Loirat, A. Bertucci, B. Renouf, F. C. Bidard, F. Lerebours

Publikováno v: Oncogene. 42:1417-1417

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a0f530883623834d908e5af7f24766c6
https://doi.org/10.1038/s41388-023-02615-8

553P Real-world data on dostarlimab in post-platinum mismatch repair deficient (dMMR)/ microsatellite instability high (MSI-H) advanced/recurrent (A/R) endometrial cancer: Descriptive analysis of the French cohort temporary authorization of use (ATU)

Autor: M.J. Rodrigues, L. Eberst, P. Follana, V. Brunel, L. Gauthier, V.J. Jacquemin, C. Tessier, N. El Mouaddin, P. Boudier, F. Fiteni, E. Angeli, S. Roche, I. Bonnet, C. Deldycke, N. Delanoy, R. Sabatier, R. Flippot, T. De La Motte Rouge

Publikováno v: Annals of Oncology. 33:S801-S802

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::863b54d750ca789db5dc601dbc8cfa81
https://doi.org/10.1016/j.annonc.2022.07.681